Your browser doesn't support javascript.
loading
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial.
Ogura, Michinori; Sancho, Juan Manuel; Cho, Seok-Goo; Nakazawa, Hideyuki; Suzumiya, Junji; Tumyan, Gayane; Kim, Jin Seok; Lennard, Anne; Mariz, José; Ilyin, Nikolai; Jurczak, Wojciech; Lopez Martinez, Aurelio; Samoilova, Olga; Zhavrid, Edvard; Yañez Ruiz, Eduardo; Trneny, Marek; Popplewell, Leslie; Coiffier, Bertrand; Buske, Christian; Kim, Won-Seog; Lee, Sang Joon; Lee, Sung Young; Bae, Yun Ju; Kwak, Larry W.
Afiliação
  • Ogura M; Department of Haematology and Oncology, Kasugai Municipal Hospital, Kasugai, Japan; School of Medicine, Fujita Medical University, Toyoake, Japan.
  • Sancho JM; Hematology Department, The Catalan Institute of Oncology-The Josep Carreras Leukaemia Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Cho SG; Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
  • Nakazawa H; Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Suzumiya J; Shimane University Hospital, Innovative Cancer Center/Oncology-Hematology, Izumo, Japan.
  • Tumyan G; Division of Hematology and Bone Marrow Transplantation, N N Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Kim JS; Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea.
  • Lennard A; Northern Institute for Cancer Care, Newcastle University, Newcastle-upon-Tyne, UK.
  • Mariz J; Department of Onco-Hematology, Portuguese Institute of Oncology, Porto, Portugal.
  • Ilyin N; Russian Research Center for Radiology and Surgical Technologies, Ministry of Health of the Russian Federation, St Petersburg, Russia.
  • Jurczak W; Department of Haematology, Jagiellonian University, Kraków, Poland.
  • Lopez Martinez A; Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain.
  • Samoilova O; Department of Hematology, Nizhniy Novgorod Region Clinical Hospital, Nizhniy Novgorod, Russia.
  • Zhavrid E; N N Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Minsk, Belarus.
  • Yañez Ruiz E; Department of Internal Medicine, Universidad de la Frontera, Temuco, Chile.
  • Trneny M; Department of Medicine, Charles University, General Hospital in Prague, Prague, Czech Republic.
  • Popplewell L; Toni Stephenson Lymphoma Center and Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
  • Coiffier B; Department of Hematology, Hospices Civils de Lyon, Lyon, France.
  • Buske C; Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany.
  • Kim WS; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lee SJ; Celltrion, Inc., Incheon, South Korea.
  • Lee SY; Celltrion, Inc., Incheon, South Korea.
  • Bae YJ; Celltrion, Inc., Incheon, South Korea.
  • Kwak LW; Toni Stephenson Lymphoma Center and Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA. Electronic address: lkwak@fsm.northwestern.edu.
Lancet Haematol ; 5(11): e543-e553, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30389036
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segurança / Linfoma Folicular / Carga Tumoral / Anticorpos Monoclonais Murinos / Rituximab Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segurança / Linfoma Folicular / Carga Tumoral / Anticorpos Monoclonais Murinos / Rituximab Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2018 Tipo de documento: Article